Universe Pharmaceuticals Inc.
UPC · NASDAQ
9/30/2024 | 9/30/2023 | 9/30/2022 | 9/30/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | -$0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -28.7% | -19.5% | -16.3% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 26.4% | 31.9% | 54.5% | 52.8% |
| EBITDA | -$0 | -$0 | -$0 | $0 |
| % Margin | -32% | -9.9% | -15.9% | 29.6% |
| Net Income | -$0 | -$0 | -$0 | $0 |
| % Margin | -37.9% | -19.1% | -21.8% | 23.6% |
| EPS Diluted | -1,436.12 | -1,040.53 | -1,475.02 | 2,147.18 |
| % Growth | -38% | 29.5% | -168.7% | – |
| Operating Cash Flow | -$0 | $0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | $0 | -$0 | -$0 |